These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8609399)

  • 21. Differential susceptibility of naïve versus cloned CD4+ T cells to antigen-specific and MHC-restricted anergy induction.
    Liu QS; Zhang RH; Chu YW; Xiong SD
    Sheng Li Xue Bao; 2003 Dec; 55(6):633-40. PubMed ID: 14695478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An altered peptide ligand specifically inhibits Th2 cytokine synthesis by abrogating TCR signaling.
    Faith A; Akdis CA; Akdis M; Joss A; Wymann D; Blaser K
    J Immunol; 1999 Feb; 162(3):1836-42. PubMed ID: 9973449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A combinatorial peptide library around variation of the human immunodeficiency virus (HIV-1) V3 domain leads to distinct T helper cell responses.
    Estaquier J; Boutillon C; Georges B; Ameisen JC; Tartar A; Auriault C
    J Pept Sci; 1996; 2(3):165-75. PubMed ID: 9231325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suboptimal activation of CD8(+) T cells by melanoma-derived altered peptide ligands: role of Melan-A/MART-1 optimized analogues.
    Carrabba MG; Castelli C; Maeurer MJ; Squarcina P; Cova A; Pilla L; Renkvist N; Parmiani G; Rivoltini L
    Cancer Res; 2003 Apr; 63(7):1560-7. PubMed ID: 12670905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of global anergy rather than inhibitory Th2 lymphokines mediates posttrauma T cell immunodepression.
    De AK; Kodys KM; Pellegrini J; Yeh B; Furse RK; Bankey P; Miller-Graziano CL
    Clin Immunol; 2000 Jul; 96(1):52-66. PubMed ID: 10873428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Requirements for stimulation or anergy induction in alloreactive human T cell clones.
    Pawelec G; Kalbacher H; Pohla H; Boshell M; Max H; Friccius H; Adibzadeh M; Hambrecht A; Sansom D
    Cell Immunol; 1994 Oct; 158(1):241-52. PubMed ID: 7522128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo T helper cell response to retro-inverso peptidomimetics.
    Mézière C; Viguier M; Dumortier H; Lo-Man R; Leclerc C; Guillet JG; Briand JP; Muller S
    J Immunol; 1997 Oct; 159(7):3230-7. PubMed ID: 9317121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered peptide ligands of islet autoantigen Imogen 38 inhibit antigen specific T cell reactivity in human type-1 diabetes.
    Geluk A; van Meijgaarden KE; Roep BO; Ottenhoff TH
    J Autoimmun; 1998 Aug; 11(4):353-61. PubMed ID: 9776713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular mechanisms involved in protection against influenza virus infection in transgenic mice expressing a TCR receptor specific for class II hemagglutinin peptide in CD4+ and CD8+ T cells.
    Bot A; Casares S; Bot S; von Boehmer H; Bona C
    J Immunol; 1998 May; 160(9):4500-7. PubMed ID: 9574556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of an epitope of the human cytomegalovirus protein IE1 recognized by a CD4+ T cell clone.
    Gautier N; Chavant E; Prieur E; Monsarrat B; Mazarguil H; Davrinche C; Gairin JE; Davignon JL
    Eur J Immunol; 1996 May; 26(5):1110-7. PubMed ID: 8647175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR.
    Doherty DG; Penzotti JE; Koelle DM; Kwok WW; Lybrand TP; Masewicz S; Nepom GT
    J Immunol; 1998 Oct; 161(7):3527-35. PubMed ID: 9759873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modification of peptide interaction with MHC creates TCR partial agonists.
    Ryan KR; McNeil LK; Dao C; Jensen PE; Evavold BD
    Cell Immunol; 2004 Jan; 227(1):70-8. PubMed ID: 15051516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigen-experienced T cells undergo a transient phase of unresponsiveness following optimal stimulation.
    De Mattia F; Chomez S; Van Laethem F; Moulin V; Urbain J; Moser M; Leo O; Andris F
    J Immunol; 1999 Dec; 163(11):5929-36. PubMed ID: 10570279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anergy induction in human CD4+ T-cell clones by stimulation with soluble peptides does not require cell proliferation and is accompanied by elevated IL4 production.
    Grunow R; Frutig K; Pichler WJ
    Cell Immunol; 1996 Oct; 173(1):79-86. PubMed ID: 8871603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Degenerate recognition and response of human CD4+ Th cell clones: implications for basic and applied immunology.
    Nishimura Y; Chen YZ; Uemura Y; Tanaka Y; Tsukamoto H; Kanai T; Yokomizo H; Yun C; Matsuoka T; Irie A; Matsushita S
    Mol Immunol; 2004 Feb; 40(14-15):1089-94. PubMed ID: 15036913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The immunogenic potential of human fetal retinal pigment epithelium and its relation to transplantation.
    Rezai KA; Semnani RT; Patel SC; Ernest JT; van Seventer GA
    Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2662-71. PubMed ID: 9375586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigen presentation by interferon-gamma-treated thyroid follicular cells inhibits interleukin-2 (IL-2) and supports IL-4 production by B7-dependent human T cells.
    Lombardi G; Arnold K; Uren J; Marelli-Berg F; Hargreaves R; Imami N; Weetman A; Lechler R
    Eur J Immunol; 1997 Jan; 27(1):62-71. PubMed ID: 9021999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-2 and a contact-mediated signal provided by TCR alpha beta + or TCR gamma delta + CD4+ T cells induce polyclonal Ig production by committed human B cells. Enhancement by IL-5, specific inhibition of IgA synthesis by IL-4.
    van Vlasselaer P; Gascan H; de Waal Malefyt R; de Vries JE
    J Immunol; 1992 Mar; 148(6):1674-84. PubMed ID: 1347306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells.
    Sloan-Lancaster J; Evavold BD; Allen PM
    Nature; 1993 May; 363(6425):156-9. PubMed ID: 8483498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T-cell receptor-mediated anergy of a human immunodeficiency virus (HIV) gp120-specific CD4(+) cytotoxic T-cell clone, induced by a natural HIV type 1 variant peptide.
    Bouhdoud L; Villain P; Merzouki A; Arella M; Couture C
    J Virol; 2000 Mar; 74(5):2121-30. PubMed ID: 10666241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.